CSF2RB and acute myeloid leukemia: Charlet et al. (2022) investigated the role of CSF2RB in FMS-like tyrosine kinase 3 receptor (FLT3)-internal tandem duplication (ITD)-positive AML through in vitro and in vivo studies and confirmed CSF2RB/FLT3-ITD interaction in human primary leukemic cells and cell lines with FLT3-ITD mutation.